IL-15-based molecules and methods of use thereof
US10537615B2 · kind B2 · utility
23Cited by
0References
7Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 14, 2018 |
| Grant date | Jan 21, 2020 |
| Priority date | — |
| Expiry date | Mar 17, 2038 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2319/32
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention features combination therapies using an IL-15-based superagonist complex and an antibody to effectively treat subjects with cancer and infectious diseases.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.